According to a press release from the National Cannabis Industry Association (NCIA), a standalone cannabis policy reform bill was brought before the House of Representatives for a vote on Wednesday, September 25, 2019 and passed with an overwhelming bipartisan majority.
The National Center for Complementary and Integrative Health (NCCIH), part of the NIH, announced funding for nine new research awards totaling $3 million to study the potential pain-relieving properties of cannabinoids and terpenes in cannabis.
Cannabis Science and Technology is pleased to announce the addition of Benjamin A. Katchman, PhD, to its editorial advisory board (EAB).
The U.S. Drug Enforcement Administration (DEA) announced in a press release (1) that it is moving forward to facilitate and expand scientific and medical research for cannabis in the United States.
Lake Superior State University (LSSU) announced a strategic partnership with Agilent Technologies to facilitate education and research in cannabis chemistry and analysis through the LSSU Cannabis Center of Excellence (CoE).
GW Pharmaceuticals recently announced the company’s financial results from the second quarter of 2019.
University of the Sciences announced a new program for students interested in the cannabis industry: a specialized Cannabis Industry Masters of Business Administration (MBA) option.
Big Pharma is working on locking up cannabis patents, creating partnerships, and standing by to use its financial muscle for more ownership of the medical cannabis industry when the time is right.
Nearly every state has to weather the argument from law enforcement about how to find and get stoned drivers off the road. But developing roadside testing devices to use for finding reliable, standardized levels of THC intoxication continues to be a slippery, moving problem with no solution in sight.
Small Business Administration Congressional Hearing: Another Milestone for the Cannabis Industry, Featuring Detractors Offering Inadvertent Support
Another Congressional hearing pits detractors against industry businesses testifying about getting access to financial services like any other small business.